CTRI/2021/07/034640尚未招募3 期
A Multicentric, Open label, Prospective, Observational Study to evaluate effect of Individualised Homoeopathic Medicines in Tinea Corporis and Tinea Cruris
Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients aged 18-65 years with Tinea corporis/cruris.
- •Both male and female
- •Patientâ??s positive with Mycological findings
排除标准
- •Patients using topical ointments /systemic treatment for tinea in past 15days.
- •Evidence of skin conditions (like Tinea pedis/ barbae/ unguium, Pityriasis versicolor/ Alba, vitiligo, Psoriasis, Eczema, Lichen planus) other than Tinea corporis / Cruris that would interfere with evaluations of the effect of study medication.
- •Patients taking treatment with immune-modulating oral medications in past one (1) month.
- •Cases associated with any systemic diseases and their complications (like Diabetes mellitus, primary or secondary Hypertension, Thyroid disorders, Any heart diseases, Renal failure or Hepatic failure, any type of malignancy, HIV, Tuberculosis, Filariasis).
- •Pregnant or Lactating women.
- •Unwilling to participate the study.
研究者
相似试验
已完成
不适用
A prospective, open label, multi-centre, observational, post-market study evaluating Juvéderm® Volift with Lidocaine for the correction of moderate to severe nasolabial folds (NLF)gezichtverouderingdermal fillersfacial agingNL-OMON37130Allergan Pharmaceuticals Ireland23
Unknown
4 期
A study to understand safety and effectiveness of Abiraterone acetate (an anti-cancer medicine) in patients with cancer of prostate glandCTRI/2018/06/014592Glenmark Pharmaceuticals Ltd
招募中
4 期
Centralized monitoring study for safety of Traditional Chinese Medicine granulesadverse drug reactionITMCTR2000003180First Affiliated Hospital of Guang zhou University of Chinese Medicine
招募中
不适用
An observational registry study of ISAR SUMMIT coronary stent system in coronary artery diseased patients of Indian populatioCTRI/2022/07/044472Dr Praveen Chandra
招募中
4 期
A post marketing surveillance study to evaluate safety and efficacy of fixed dose combination of Ceftriaxone + Sulbactam (Sulbactomax) in patients with various bacterial infectionsCTRI/2012/04/002558Venus Remedies Limited2,500